Compare GTBP & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTBP | ABTS |
|---|---|---|
| Founded | 1965 | 2010 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 14.1M |
| IPO Year | N/A | N/A |
| Metric | GTBP | ABTS |
|---|---|---|
| Price | $0.66 | $6.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 21.5K |
| Earning Date | 11-14-2025 | 08-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,059,040.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.69 |
| 52 Week Low | $0.54 | $1.35 |
| 52 Week High | $4.10 | $14.10 |
| Indicator | GTBP | ABTS |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 45.31 |
| Support Level | $0.58 | $5.67 |
| Resistance Level | $0.82 | $6.26 |
| Average True Range (ATR) | 0.07 | 0.62 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 32.15 | 26.32 |
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.